Seeking Alpha

Retail Investor

 
View as an RSS Feed
View Retail Investor's Comments BY TICKER:
Latest  |  Highest rated
  • Momenta Pharmaceuticals Heading For A Repeat [View article]
    mnta has been one of the worst investments ...look at how much shareholder value they have added since that ceo took over 3-4 years ago. word "long term" is misused.
    Aug 17 01:10 AM | Likes Like |Link to Comment
  • Vringo: Could It Be Worth $2 Billion? [View article]
    vringo , worth $2 billion ?!
    Aug 16 11:23 AM | Likes Like |Link to Comment
  • magicJack: Short-Term Catalyst, And Significant Upside [View article]
    truthfreedom - you ask absolutely the most pertinent questions here. I wondered the same over the weekend. The best explanation for shorts I could think is the decline in revenue because magicjackgo imo is not needed if you have magicjack app. right now magicjack app is free.

    but have shorts thought abt scenario where magicjackapp becomes some 30m users and the valuation becomes more like whatsapp ?
    dont know. But is there any other company that can copy what magicjack app does ? Don't know..are shorts aware ?. Do the patents protect another company from doing it?
    Otherwise longs will be rewarded
    Aug 11 12:41 PM | 1 Like Like |Link to Comment
  • Juicy Details From The Allergan Lawsuit: Why Valeant And Ackman May Be In More Trouble Than They Are Letting On [View article]
    Uncommon,

    You have an uncommon interest in writing about stocks you are neither long or short. Your pseudonym also has words "profit investor". Why don't you profit from your uncommon interest in bashing $VRX and glorifying $AGN by investing long or short these equities ?

    I'll give you another opportunity to come clean.
    Aug 7 08:42 AM | Likes Like |Link to Comment
  • Juicy Details From The Allergan Lawsuit: Why Valeant And Ackman May Be In More Trouble Than They Are Letting On [View article]
    Uncommon,
    your articles are very detailed. However, you have to come clean in terms of your "uncommon" interest in writing ONLY articles about AGN/VRX/Ackman. You say you are not short VRX nor are you long AGN. Are you aligned with somebody to write negative about Ackman/VRX?
    thank you
    REtail
    Aug 4 11:35 AM | Likes Like |Link to Comment
  • The Product Development Story Of Provectus Biopharmaceuticals [View article]
    Agreed WallCFA. Unfortunately the scheme will be perpetrated on novice "investors" (suckers). Look at the delusional and misleading posts by this schemester http://bit.ly/1ljzc6n
    Aug 1 11:56 AM | Likes Like |Link to Comment
  • The Product Development Story Of Provectus Biopharmaceuticals [View article]
    Yo Alan, I have seen many like you in my life. PVCT as far as I can tell has all the inklings of a scheme. Of course it is my opinion. If the rose bengal was worth anything they would have been able to get a partner YEARS AGO. Are you the delusional blogger that has "made academic travels" to ivy league and is commissioned to tout this as $60 per share?
    Jul 31 09:55 PM | 1 Like Like |Link to Comment
  • The Product Development Story Of Provectus Biopharmaceuticals [View article]
    you said: " the run up to $5 (actually $6) was due to overly excited investors thinking BTD was going to be approved"

    Who do you think was responsible for pumping this ? just asking. you and me know who were involved. BTD is meaningless but yet they managed to suck investors into the hype(word hype is a euphemism). All responsible people of this scheme should be investigated and charged. Unfortunately retail gets sucked to this.
    Jul 30 09:21 PM | Likes Like |Link to Comment
  • The Product Development Story Of Provectus Biopharmaceuticals [View article]
    When I say a stock is manipulated, I meant both climb up and climb down. Difficult to investigate who is involved in this manipulation game. I insist if PVCT's rose bengal was worth anything, it would have attracted partnership interest long time back. A stock climbing from 80 cents to $5 with no material news should automatically attract SEC's attention. the whole pump on "BTD" didn't make an iota of sense...but guess what 70% of retail are suckers. Who were the buyers (suckers?)? Who short sold at $6 (anybody that knew this scheme?)?
    Jul 30 08:02 PM | Likes Like |Link to Comment
  • The Product Development Story Of Provectus Biopharmaceuticals [View article]
    glad we could agree on something. GLTU
    Jul 30 04:29 AM | Likes Like |Link to Comment
  • The Product Development Story Of Provectus Biopharmaceuticals [View article]
    why has PVCT been promising that a partnership deal is in works for so many years ? i had read all its pr's dating back to 2010, 2011...Those pr's made it sound like partnership deal was the main thing to look forward to as a shareholder.

    Dr Agarwala's scandal is stinking enough for me. Do we know how he is getting compensated by PVCT for whatever he is saying on Rose bengal? Dr Agarwala's video touting Rose bengal's cancer curing abilities isn't convincing either

    I have not seen any biotech stock climbing 6 times on NO MATERIAL NEWS. In my opinion, it just means it is manipulated stock.
    Jul 30 02:21 AM | 1 Like Like |Link to Comment
  • The Product Development Story Of Provectus Biopharmaceuticals [View article]
    Comparing Alfrezza to Rose bengal solution is comparing apples and tomato. get it? what do you think of Dr. Agarwala? Have you seen his background ? What do you think of stock compensation to the only 2 or 3 employees of PVCT? What do you think of that blogger who has been pumping PVCT with $60 per share targets? What do you think of the stock price increase from 80 cents to $5 per share with no material news ?
    Jul 30 12:25 AM | Likes Like |Link to Comment
  • The Product Development Story Of Provectus Biopharmaceuticals [View article]
    Micheal, Yes, I am being serious. PVCT , in my opinion, is shady. If the product was worth anything , they would have long done a partnership deal. Why does pvct release PR every few weeks ? When it is all said and done a lot of "investors"(gamblers) would have lost money here.
    Jul 29 10:03 PM | Likes Like |Link to Comment
  • The Product Development Story Of Provectus Biopharmaceuticals [View article]
    If pVCT's product had any market potential, PVCT would have completed partnership 3 or 4 years ago. Phase 3 trial has not been started for nearly 4 years. PVCT's investigator is the same guy who was behind VICL's failed phase 3.
    Why does PVCT "release" PR's every week ? Instead they had opportunity to either do a partnership deal or start phase 3 in the last 3-4 years.
    Jul 29 09:26 PM | 1 Like Like |Link to Comment
  • The Product Development Story Of Provectus Biopharmaceuticals [View article]
    i have a strong feeling PVCT is just like the VICL pump. investors will lose ton of money. They have taken 4 years to even start a p3 and 100's of press releases. Why?
    Jul 28 11:12 PM | 3 Likes Like |Link to Comment
COMMENTS STATS
421 Comments
240 Likes